Aspiriant LLC’s iShares Select U.S. REIT ETF ICF Stock Holding History
Bought
Maintained
Sold
Other funds holding ICF
CFB
ANTB
Aspiriant LLC's ICF Position: Q3 2022 in Review
Aspiriant LLC sold out of iShares Select U.S. REIT ETF (ICF) in Q3 2022, closing a stake of 4,960 shares — an estimated $302K sold.
Aspiriant LLC first reported a position in ICF in Q2 2013 and held it in 21 quarters. The position peaked at $1.32M in Q2 2013. 351 funds tracked by Wall St. Rank hold ICF as of Q3 2022.
- Aspiriant LLC reported no remaining iShares Select U.S. REIT ETF position as of Q3 2022 after selling out during the quarter.
- Aspiriant LLC sold 4,960 iShares Select U.S. REIT ETF shares in Q3 2022, an estimated $302K.
- Aspiriant LLC first reported a position in iShares Select U.S. REIT ETF in Q2 2013 and held it in 21 quarters.
- Aspiriant LLC's iShares Select U.S. REIT ETF position peaked at $1.32M in Q2 2013.
- 351 funds tracked by Wall St. Rank held iShares Select U.S. REIT ETF as of Q3 2022.
Based on Aspiriant LLC's 13F filing for Q3 2022, filed 28 Oct 2022.